APA (7th ed.) Citation

Riva, C., Minetto, P., Nicoletta, S., Romei, R., Chies, M., Zecchetti, G., . . . Guolo, F. (2025, September). DP031 | PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY AML TREATED WITH CPX-351: A FOCUS ON MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL. Haematologica.

Chicago Style (17th ed.) Citation

Riva, C., et al. "DP031 | PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY AML TREATED WITH CPX-351: A FOCUS ON MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL." Haematologica Sep. 2025.

MLA (9th ed.) Citation

Riva, C., et al. "DP031 | PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY AML TREATED WITH CPX-351: A FOCUS ON MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL." Haematologica, Sep. 2025.